Key statistics
As of last trade Bicycle Therapeutics PLC (50BA:STU) traded at 19.00, -26.36% below its 52-week high of 25.80, set on Feb 28, 2024.
52-week range
Open | 18.80 |
---|---|
High | 19.00 |
Low | 18.70 |
Bid | 18.70 |
Offer | 20.20 |
Previous close | 19.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 69.05m |
Free float | 4.33m |
P/E (TTM) | -- |
Market cap | 1.40bn USD |
EPS (TTM) | -3.28 USD |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Press releases
- Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
- Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
- CORRECTING and REPLACING BioMed Realty Ranks Number One in 2024 ESG Achievements
- Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals
- Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress
- Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024
More ▼